WO2024254612A3 - Agent de contraste ultrasonore activé par ultrasons - Google Patents

Agent de contraste ultrasonore activé par ultrasons Download PDF

Info

Publication number
WO2024254612A3
WO2024254612A3 PCT/US2024/033302 US2024033302W WO2024254612A3 WO 2024254612 A3 WO2024254612 A3 WO 2024254612A3 US 2024033302 W US2024033302 W US 2024033302W WO 2024254612 A3 WO2024254612 A3 WO 2024254612A3
Authority
WO
WIPO (PCT)
Prior art keywords
ultrasound
contrast agent
activated
sterilized
amino groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/033302
Other languages
English (en)
Other versions
WO2024254612A2 (fr
Inventor
Travis J. Williams
Jesse Tong-Pin Yen
Van Khanh DO
Andy Yu-How CHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital Los Angeles
University of Southern California USC
Original Assignee
Childrens Hospital Los Angeles
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Los Angeles, University of Southern California USC filed Critical Childrens Hospital Los Angeles
Publication of WO2024254612A2 publication Critical patent/WO2024254612A2/fr
Publication of WO2024254612A3 publication Critical patent/WO2024254612A3/fr
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/48—Diagnostic techniques
    • A61B8/481—Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un agent de contraste ultrasonore activé par ultrasons comprend un support liquide stérilisé; et un polymère stérilisé dispersé et/ou dissous dans le support liquide stérilisé. De manière avantageuse, le polymère stérilisé comprend des groupes amino qui sont au moins partiellement fonctionnalisés avec du CO2 au niveau d'une pluralité des groupes amino.
PCT/US2024/033302 2023-06-09 2024-06-10 Agent de contraste ultrasonore activé par ultrasons Pending WO2024254612A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363471994P 2023-06-09 2023-06-09
US63/471,994 2023-06-09

Publications (2)

Publication Number Publication Date
WO2024254612A2 WO2024254612A2 (fr) 2024-12-12
WO2024254612A3 true WO2024254612A3 (fr) 2025-05-08

Family

ID=93796432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/033302 Pending WO2024254612A2 (fr) 2023-06-09 2024-06-10 Agent de contraste ultrasonore activé par ultrasons

Country Status (1)

Country Link
WO (1) WO2024254612A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1232837A (fr) * 1983-04-15 1988-02-16 Jurgen Hilmann Agent contrastant ultrasonique contenant des microparticules et microbulles de gaz

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1232837A (fr) * 1983-04-15 1988-02-16 Jurgen Hilmann Agent contrastant ultrasonique contenant des microparticules et microbulles de gaz

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG ANDY Y, SYED HELAL, NUSSBAUM ZOE, DO VAN, WILLIAMS TRAVIS J, YEN JESSE T: "Selective release of CO2-loaded nanoparticles for vesicoureteral reflux imaging", PEDIATRIC UROLOGY FALL CONGRESS, SOCIETY FOR PEDIATRIC UROLOGY, US, 21 September 2023 (2023-09-21), US, pages 1 - 2, XP093311827, Retrieved from the Internet <URL:https://fallcongress.spuonline.org/program/2023/53.cgi> *
HAN XIANGJUN, XU KE, TARATULA OLENA, FARSAD KHASHAYAR: "Applications of nanoparticles in biomedical imaging", NANOSCALE, vol. 11, no. 3, 17 January 2019 (2019-01-17), UK, pages 799 - 819, XP093311821, ISSN: 2040-3364, DOI: 10.1039/C8NR07769J *
LUO WENLI, LI ZHAOJIAN, ZHANG LING, XIE XINGYI: "Polyethylenimine-CO2 adduct templated CaCO3 nanoparticles as anticancer drug carrier", CANCER NANOTECHNOLOGY, vol. 14, no. 7, 1 December 2023 (2023-12-01), AT, pages 1 - 21, XP093311789, ISSN: 1868-6958, DOI: 10.1186/s12645-023-00156-z *
ZHANG KUN, XU HUIXIONG, CHEN HANGRONG, JIA XIAOQING, ZHENG SHUGUANG, CAI XIAOJUN, WANG RONGHUI, MOU JUAN, ZHENG YUANYI, SHI JIANLI: "CO 2 bubbling-based 'Nanobomb' System for Targetedly Suppressing Panc-1 Pancreatic Tumor via Low Intensity Ultrasound-activated Inertial Cavitation", THERANOSTICS, vol. 5, no. 11, 12 September 2015 (2015-09-12), AU , pages 1291 - 1302, XP093311803, ISSN: 1838-7640, DOI: 10.7150/thno.12691 *
ZHAO CHONG, ZHOU BENQING: "Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics", JOURNAL OF FUNCTIONAL BIOMATERIALS, vol. 14, no. 1, CH , pages 12 - 12-27, XP093311812, ISSN: 2079-4983, DOI: 10.3390/jfb14010012 *
ZHOU BENQING, XIONG ZUOGANG, WANG PENG, PENG CHEN, SHEN MINGWU, MIGNANI SERGE, MAJORAL JEAN-PIERRE, SHI XIANGYANG: "Targeted tumor dual mode CT/MR imaging using multifunctional polyethylenimine-entrapped gold nanoparticles loaded with gadolinium", DRUG DELIVERY, vol. 25, no. 1, 1 January 2018 (2018-01-01), US , pages 178 - 186, XP093311816, ISSN: 1071-7544, DOI: 10.1080/10717544.2017.1422299 *

Also Published As

Publication number Publication date
WO2024254612A2 (fr) 2024-12-12

Similar Documents

Publication Publication Date Title
EP4467599A3 (fr) Copolymères greffés d&#39;alpha-1,3-glucane
CA2042722A1 (fr) Microbulles d&#39;air ou de gaz polymerique utilisees en suspension dans les supports liquides en echographie
WO2020012314A3 (fr) Composition de polyéthylène et film
ATE460437T1 (de) Polymere von fluormonomeren und hydrophilen monomeren
MXPA02011111A (es) Polimeros biocidas a base de sales de guanidina.
WO2006004941A3 (fr) Biomateriel
EA200702341A1 (ru) Пропиленовый полимер с высокой степенью кристалличности
WO2005069966A3 (fr) Greffes vasculaires a revetement a base de copolymere sequence amphiphile
ATE400306T1 (de) Blut und/oder körperflüssigkeiten absorbierende polymerpartikel
ATE410473T1 (de) Polymerstrukturen mit einem hydrophil/lipophil- system
WO2005051456A3 (fr) Composition et appareil d&#39;administration transdermique
EP2319542A3 (fr) Polymères dégradables segmentés et conjugués obtenus à partir de ceux-ci
DE60142897D1 (de) Polymermembranzusammensetzung
BR0303493A (pt) Combinação de polìmero de antibiótico/antibióticos
WO2020012313A3 (fr) Composition de polyéthylène et film ayant des performances conservées à l&#39;impact de masse tombante
ATE418591T1 (de) Wasserkontaktindikator
WO2024254612A3 (fr) Agent de contraste ultrasonore activé par ultrasons
IL115181A (en) Contrast agent consisting of repeating biodegradable units its use and preparation
Correia et al. Anti-biofouling 3D porous systems: the blend effect of oxazoline-based oligomers on chitosan scaffolds
EP1595917A4 (fr) Dispersion aqueuse
AU2003213152A1 (en) Hydrolytically degradable alkylene oxide based polymers
DE60121955D1 (de) Filmpolymer
PT1773399E (pt) Hidrogéis de ácido hialurónico e alfa, beta-poliaspartilhidrazida e as suas utilizações biomédicas e farmacêuticas
WO2006016670A8 (fr) Agent antistatique, film antistatique et produit recouvert du film antistatique
DE602006006854D1 (de) Feststoffpigment-konzentrate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24820241

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE